Sagespring Wealth Partners LLC Purchases Shares of 6,250 Aflac Incorporated (NYSE:AFL)

Sagespring Wealth Partners LLC acquired a new position in shares of Aflac Incorporated (NYSE:AFL - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 6,250 shares of the financial services provider's stock, valued at approximately $647,000.

Other institutional investors also recently made changes to their positions in the company. Whipplewood Advisors LLC bought a new stake in Aflac in the 4th quarter valued at $26,000. BankPlus Trust Department bought a new stake in shares of Aflac in the fourth quarter valued at about $34,000. Curio Wealth LLC acquired a new position in shares of Aflac in the fourth quarter valued at about $36,000. OFI Invest Asset Management bought a new position in Aflac during the fourth quarter worth about $38,000. Finally, Rialto Wealth Management LLC bought a new stake in Aflac in the 4th quarter valued at about $41,000. Institutional investors own 67.44% of the company's stock.

Aflac Price Performance

Shares of NYSE AFL traded up $0.01 during mid-day trading on Friday, hitting $107.35. 2,294,639 shares of the stock traded hands, compared to its average volume of 2,143,134. Aflac Incorporated has a twelve month low of $80.11 and a twelve month high of $115.50. The firm has a 50 day simple moving average of $106.64 and a two-hundred day simple moving average of $107.37. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The company has a market cap of $58.59 billion, a PE ratio of 11.18, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81.

Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, equities research analysts forecast that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Insider Buying and Selling at Aflac

In other Aflac news, Director Charles D. Lake II sold 29,802 shares of the company's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the sale, the director now owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. This represents a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. UBS Group boosted their price target on Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a research note on Wednesday, April 2nd. Keefe, Bruyette & Woods cut their target price on Aflac from $107.00 to $104.00 and set a "market perform" rating for the company in a research report on Wednesday, February 12th. Piper Sandler raised their price target on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. StockNews.com raised shares of Aflac from a "sell" rating to a "hold" rating in a research report on Friday, February 14th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Aflac from $94.00 to $96.00 and gave the company a "neutral" rating in a research report on Wednesday, April 2nd. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $103.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.